
On Monday, the EU Commission authorized Bavarian Nordic to broaden its vaccine label for smallpox vaccine Imvanex, adding monkeypox. This followed hot on the heels of the European Medicines Agency’s approval recommendation on Friday.
While that took place, the World Health Organization (WHO) decided to categorize the monkeypox outbreak as a global health emergency, the authority’s highest level of alert.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app